Louisiana 2014 2014 Regular Session

Louisiana House Bill HB212 Comm Sub / Analysis

                    DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part of
the legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute part of
the law or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
LeBas	HB No. 212
Abstract: Adds certain substances to Schedules II, III, and IV.
Present law provides for the designation of controlled dangerous substances into Schedules I, II,
III, IV, and V based upon the substances' potential for addiction and abuse.
Proposed law retains present law.
Proposed law adds 4-anilino-N-phenethyl-4-piperidine (ANPP) as an immediate precursor to
fentanyl to Schedule II.
Proposed law adds perampanel, methasterone and prostanozol to Schedule III.
Proposed law adds lorcaserin and alfaxalone to Schedule IV.
(Amends R.S. 40:964(Schedule IV)(B)(1); Adds R.S. 40:964(Schedule II)(E)(3), (Schedule
III)(B)(15), (E)(29.1) and (53.1), (Schedule IV)(B)(1.5) and (Schedule IV)(D)(13))
Summary of Amendments Adopted by House
Committee Amendments Proposed by 	House Committee on Administration of Criminal
Justice to the original bill.
1. Added methasterone and prostanozol to Schedule III.
2. Added alfaxalone to Schedule IV.